Troy E. Messick

1.5k total citations
34 papers, 1.1k citations indexed

About

Troy E. Messick is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Troy E. Messick has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Pathology and Forensic Medicine and 12 papers in Molecular Biology. Recurrent topics in Troy E. Messick's work include Viral-associated cancers and disorders (18 papers), Lymphoma Diagnosis and Treatment (12 papers) and Cytomegalovirus and herpesvirus research (8 papers). Troy E. Messick is often cited by papers focused on Viral-associated cancers and disorders (18 papers), Lymphoma Diagnosis and Treatment (12 papers) and Cytomegalovirus and herpesvirus research (8 papers). Troy E. Messick collaborates with scholars based in United States, France and Hong Kong. Troy E. Messick's co-authors include Roger A. Greenberg, Paul M. Lieberman, Genze Shao, Jeffrey Patterson-Fortin, Ronen Marmorstein, Julianna S. Deakyne, Yingqun Wang, Dan Feng, Jayaraju Dheekollu and Niraj M. Shanbhag and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Troy E. Messick

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Troy E. Messick United States	19	683	493	213	185	159	34	1.1k
Feroz Sarkari Canada	9	659 1.0×	518 1.1×	114 0.5×	99 0.5×	228 1.4×	10	930
Aaron K. Neumann United States	17	526 0.8×	240 0.5×	92 0.4×	153 0.8×	120 0.8×	26	950
Jack Liao Canada	11	912 1.3×	335 0.7×	120 0.6×	66 0.4×	112 0.7×	16	1.1k
Monique Buisson France	18	883 1.3×	566 1.1×	139 0.7×	212 1.1×	235 1.5×	38	1.5k
Carlos P. Rubbi United Kingdom	18	1.3k 1.9×	594 1.2×	96 0.5×	42 0.2×	91 0.6×	31	1.6k
Yan Coulombe Canada	24	1.4k 2.0×	409 0.8×	249 1.2×	51 0.3×	58 0.4×	39	1.6k
Eun-Kyoung Yim South Korea	12	591 0.9×	228 0.5×	85 0.4×	67 0.4×	258 1.6×	13	882
Eric Weterings United States	15	1.4k 2.1×	504 1.0×	134 0.6×	69 0.4×	50 0.3×	20	1.6k
Robert A. Olie Switzerland	16	1.1k 1.6×	361 0.7×	91 0.4×	40 0.2×	81 0.5×	26	1.3k
Leela Daya–Grosjean France	23	1.3k 1.9×	533 1.1×	246 1.2×	114 0.6×	235 1.5×	49	1.7k

Countries citing papers authored by Troy E. Messick

Since Specialization

Citations

This map shows the geographic impact of Troy E. Messick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Troy E. Messick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Troy E. Messick more than expected).

Fields of papers citing papers by Troy E. Messick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Troy E. Messick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Troy E. Messick. The network helps show where Troy E. Messick may publish in the future.

Co-authorship network of co-authors of Troy E. Messick

This figure shows the co-authorship network connecting the top 25 collaborators of Troy E. Messick. A scholar is included among the top collaborators of Troy E. Messick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Troy E. Messick. Troy E. Messick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colevas, A. Dimitrios, Zahra Talebi, Victor Lee, et al.. (2025). First-in-Human Clinical Trial of a Small-Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr–Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies. Clinical Cancer Research. 31(5). 815–823. 4 indexed citations

Poli, Adi Narayana Reddy, Ian Tietjen, Nitesh Kumar Nandwana, et al.. (2024). Design of novel and highly selective SARS-CoV-2 main protease inhibitors. Antimicrobial Agents and Chemotherapy. 68(10). e0056224–e0056224. 2 indexed citations

Salvino, Joseph M., Luis J. Montaner, Joel Cassel, et al.. (2024). Metabolomic Analysis and Antiviral Screening of a Marine Algae Library Yield Jobosic Acid (2,5-Dimethyltetradecanoic Acid) as a Selective Inhibitor of SARS-CoV-2. Journal of Natural Products. 87(6). 1513–1520. 3 indexed citations

Monaco, Maria Chiara, Samantha S. Soldan, Chenhe Su, et al.. (2023). EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls. Neurology Neuroimmunology & Neuroinflammation. 10(5). 12 indexed citations

Davis, Michael T., Nicole M. Anders, A. Dimitrios Colevas, Troy E. Messick, & Michelle A. Rudek. (2023). Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK‐2019, a selective EBNA1 inhibitor. Biomedical Chromatography. 38(2). e5775–e5775. 4 indexed citations

Soldan, Samantha S., Troy E. Messick, & Paul M. Lieberman. (2022). Therapeutic approaches to Epstein–Barr virus cancers. Current Opinion in Virology. 56. 101260–101260. 12 indexed citations

Soldan, Samantha S., Chenhe Su, Jason Lamontagne, et al.. (2021). Epigenetic Plasticity Enables CNS-Trafficking of EBV-infected B Lymphocytes. PLoS Pathogens. 17(6). e1009618–e1009618. 25 indexed citations

Dheekollu, Jayaraju, Andreas Wiedmer, Kasirajan Ayyanathan, et al.. (2021). Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance. Cell. 184(3). 643–654.e13. 37 indexed citations

Soldan, Samantha S., Drew Frase, Yue Zhang, et al.. (2021). EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer. Gastric Cancer. 24(5). 1076–1088. 25 indexed citations

10.

Malecka, Kimberly A., Jayaraju Dheekollu, Julianna S. Deakyne, et al.. (2019). Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication. Journal of Virology. 93(20). 14 indexed citations

11.

Gianti, Eleonora, Troy E. Messick, Paul M. Lieberman, & Randy J. Zauhar. (2016). Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design. Journal of Computer-Aided Molecular Design. 30(4). 285–303. 25 indexed citations

12.

Tsai, Kevin, Troy E. Messick, & Paul M. Lieberman. (2015). Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme. Current Opinion in Virology. 14. 30–40. 16 indexed citations

13.

Owusu, Benjamin Y., Namita Bansal, Larry J. Ross, et al.. (2015). Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation. ACS Medicinal Chemistry Letters. 7(2). 177–181. 18 indexed citations

14.

Domchek, Susan M., Jiang-bo Tang, Jill E. Stopfer, et al.. (2012). Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer. Cancer Discovery. 3(4). 399–405. 101 indexed citations

15.

Messick, Troy E., et al.. (2010). Development of a High-Throughput Screen for Inhibitors of Epstein-Barr Virus EBNA1. SLAS DISCOVERY. 15(9). 1107–1115. 42 indexed citations

16.

Patterson-Fortin, Jeffrey, et al.. (2010). Differential Regulation of JAMM Domain Deubiquitinating Enzyme Activity within the RAP80 Complex. Journal of Biological Chemistry. 285(40). 30971–30981. 64 indexed citations

17.

Nikkilä, Janne, Dylan Morrissey, Katri Pylkäs, et al.. (2009). Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function. Oncogene. 28(16). 1843–1852. 55 indexed citations

18.

Shao, Genze, Jeffrey Patterson-Fortin, Troy E. Messick, et al.. (2009). MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes & Development. 23(6). 740–754. 117 indexed citations

19.

Messick, Troy E., Ayaka J. Iwata, Kathryn L. Sarachan, et al.. (2008). Structural Basis for Ubiquitin Recognition by the Otu1 Ovarian Tumor Domain Protein. Journal of Biological Chemistry. 283(16). 11038–11049. 91 indexed citations

20.

Seegmiller, Adam C., et al.. (1996). Internal eliminated sequences interrupting the Oxytricha 81 locus: allelic divergence, conservation, conversions, and possible transposon origins. Molecular Biology and Evolution. 13(10). 1351–1362. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact